Abstract
Clozapine, a new antipsychotic medication, is now the first-line treatment for neuroleptic refractory schizophrenia. Preliminary observations on its efficacy in treating schizophrenic patients with co-morbid substance abuse and, particularly, schizophrenic patients with persistent aggressive behaviour suggests that clozapine may provide a useful treatment option in forensic patient populations. Potential applications of clozapine and management considerations that are relevant to the forensic setting are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 9-16 |
Number of pages | 8 |
Journal | Journal of Clinical Forensic Medicine |
Volume | 2 |
Issue number | 1 |
DOIs | |
State | Published - Mar 1995 |
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Genetics
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health